Published in EMBO J on August 01, 1990
Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc Natl Acad Sci U S A (1997) 1.61
Surface expression of the beta T cell receptor (TCR) chain in the absence of other TCR or CD3 proteins on immature T cells. EMBO J (1991) 1.30
Normal pre-B cells express a receptor complex of mu heavy chains and surrogate light-chain proteins. Proc Natl Acad Sci U S A (1991) 1.21
The omega/lambda 5 surrogate immunoglobulin light chain is expressed on the surface of transitional B lymphocytes in murine bone marrow. J Exp Med (1991) 1.11
A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines. J Exp Med (1993) 1.09
Fate of surrogate light chains in B lineage cells. J Exp Med (1996) 0.99
B29 gene products complex with immunoglobulins on B lymphocytes. Proc Natl Acad Sci U S A (1992) 0.98
Molecular requirements for the mu-induced light chain gene rearrangement in pre-B cells. EMBO J (1991) 0.98
A novel type of cell death of lymphocytes induced by a monoclonal antibody without participation of complement. J Exp Med (1995) 0.91
Appearance of the LAT protein at an early stage of B-cell development and its possible role. Immunology (2003) 0.84
A novel gene product associated with mu chains in immature B cells. EMBO J (1993) 0.84
Distinct intracellular fates of membrane and secretory immunoglobulin heavy chains in a pre-B cell line. J Cell Biol (1991) 0.83
A surrogate 15 kDa JC kappa protein is expressed in combination with mu heavy chain by human B cell precursors. EMBO J (1994) 0.80
Stimulation of kappa light-chain gene rearrangement by the immunoglobulin mu heavy chain in a pre-B-cell line. Mol Cell Biol (1993) 0.78
Counterselection against D mu is mediated through immunoglobulin (Ig)alpha-Igbeta. J Exp Med (1996) 0.76
High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell (1977) 30.04
Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem (1987) 12.04
Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature (1983) 10.90
Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell (1979) 6.03
Cellular mechanisms of immunologic tolerance. Annu Rev Immunol (1983) 4.07
Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocytes. Nature (1987) 3.50
Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Eur J Immunol (1978) 3.48
A T3-like protein complex associated with the antigen receptor on murine T cells. Nature (1986) 3.22
Antigens displayed on murine B lymphocyte precursors. J Immunol (1981) 2.91
B lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural properties. EMBO J (1988) 2.88
Evidence that murine pre-B cells synthesise mu heavy chains but no light chains. Nature (1979) 2.74
Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes. J Cell Biol (1982) 2.67
Immunoglobulin messenger RNAs in murine cell lines that have characteristics of immature B lymphocytes. Cell (1979) 2.52
Mouse pre-B cells synthesize and secrete mu heavy chains but not light chains. Cell (1980) 2.50
Allelic exclusion in transgenic mice that express the membrane form of immunoglobulin mu. Science (1987) 2.44
Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes. Nature (1987) 2.43
A second gene, VpreB in the lambda 5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes. EMBO J (1987) 2.39
A novel 34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. EMBO J (1988) 2.38
Activation of V kappa gene rearrangement in pre-B cells follows the expression of membrane-bound immunoglobulin heavy chains. EMBO J (1987) 2.31
B lymphopoiesis on stromal cell clone: stromal cell clones acting on different stages of B cell differentiation. Eur J Immunol (1988) 2.20
Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain. Nature (1987) 2.09
Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. J Virol (1984) 1.93
Effective radioiodination by lactoperoxidase and solubilisation of cell-surface proteins of cultured murine T lymphoma cells. J Immunol Methods (1975) 1.89
The regulation of growth and differentiation of a murine B cell lymphoma. II. The inhibition of WEHI 231 by anti-immunoglobulin antibodies. J Immunol (1981) 1.83
Mu heavy chains can associate with a pseudo-light chain complex (psi L) in human pre-B cell lines. Int Immunol (1989) 1.59
Subunit structure of cell surface proteins: disulfide bonding in antigen receptors, Ly-2/3 antigens, and transferrin receptors of murine T and B lymphocytes. Proc Natl Acad Sci U S A (1981) 1.58
Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood (1982) 1.52
Synthesis of immunoglobulin mu chain gene products precedes synthesis of light chains during B-lymphocyte development. Proc Natl Acad Sci U S A (1981) 1.44
The omega and iota surrogate immunoglobulin light chains. Curr Top Microbiol Immunol (1988) 1.43
Anti-Ig induces release of inositol 1,4,5-trisphosphate, which mediates mobilization of intracellular Ca++ stores in B lymphocytes. J Immunol (1986) 1.43
Frequent lambda light chain gene rearrangement and expression in a Ly-1 B lymphoma with a productive kappa chain allele. Proc Natl Acad Sci U S A (1986) 1.42
Receptor signalling and crosstalk in B lymphocytes. Immunol Rev (1987) 1.33
Lambda chain expression at different stages of ontogeny in C57BL/6, BALB/c and SJL mice. Eur J Immunol (1981) 1.28
Independent control of immunoglobulin heavy and light chain expression in a murine pre-B-cell line. Nature (1981) 1.13
Specificity, duration and mechanism of idiotype suppression induced by neonatal injection of monoclonal anti-idiotope antibodies into mice. Eur J Immunol (1984) 1.06
Protein kinase C activation blocks anti-IgM-mediated signaling BAL17 B lymphoma cells. J Immunol (1987) 1.05
Detection of ligand-activated conductive Ca2+ channels in human B lymphocytes. Cell (1988) 1.05
Analysis of surface mu-chain expression in human lymphoblastoid cell lines that do not produce light chains. J Immunol (1984) 1.03
Tunicamycin inhibits the expression of membrane IgM in the human lymphoblastoid cell line Daudi. Mol Immunol (1983) 1.03
A temperature-sensitive mutant of Abelson murine leukemia virus confers inducibility of IgM expression to transformed lymphoid cells. EMBO J (1987) 0.94
A human b-cell lymphoma synthesizing and expressing surface mu-chain in the absence of detectable light chain. Blood (1981) 0.90
Single cell analysis of calcium mobilization in anti-immunoglobulin-stimulated B lymphocytes. J Immunol (1986) 0.90
Isolation and characterization of a B lymphocyte mutant with altered signal transduction through its antigen receptor. J Exp Med (1989) 0.88
Phorbol myristate acetate inhibits increases in membrane fluidity induced by anti-IgM in B cells. J Immunol (1988) 0.84
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science (1997) 13.67
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science (1997) 8.95
A restriction map of the bacteriophage T4 genome. Mol Gen Genet (1980) 6.37
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med (2000) 6.15
Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med (2000) 4.45
Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev (2000) 4.38
Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science (1991) 3.86
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med (2001) 3.56
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48
Properties of primed suppressor T cells and their products. Transplant Rev (1975) 3.42
Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells (1996) 3.41
CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev (1996) 3.27
Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A (1989) 3.27
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci U S A (1998) 2.96
Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron (1997) 2.93
Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol (1996) 2.83
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80
Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Giant Rashba-type spin splitting in bulk BiTeI. Nat Mater (2011) 2.49
NAK is an IkappaB kinase-activating kinase. Nature (2000) 2.44
Homogenous junctional sequence of the V14+ T-cell antigen receptor alpha chain expanded in unprimed mice. Proc Natl Acad Sci U S A (1990) 2.38
Mu1B, a novel adaptor medium chain expressed in polarized epithelial cells. FEBS Lett (1999) 2.37
A role for mel-18, a Polycomb group-related vertebrate gene, during theanteroposterior specification of the axial skeleton. Development (1996) 2.33
Identification of mouse ULK1, a novel protein kinase structurally related to C. elegans UNC-51. Biochem Biophys Res Commun (1998) 2.31
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A (2000) 2.30
Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma. Nature (1979) 2.28
Molecular cloning of engrailed: a gene involved in the development of pattern in Drosophila melanogaster. Cell (1985) 2.26
Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med (2000) 2.25
Antitumor action of some Basidiomycetes, especially Phllinus linteus. Gan (1968) 2.25
A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J (2001) 2.22
Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development (2001) 2.21
Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med (1997) 2.17
Eukaryotic DNA polymerases: proposal for a revised nomenclature. J Biol Chem (2001) 2.15
Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13
Properties of antigen-specific suppressive T cell factor in the regulation of antibody response of the mouse. II. In vitro activity and evidence for the I region gene product. J Immunol (1976) 2.12
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. III. Dual gene control of the T-cell-mediated suppression of the antibody response. J Exp Med (1976) 2.12
B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J Exp Med (1987) 2.09
T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state. Immunol Rev (1987) 2.07
Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol (1995) 2.02
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01
A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy. Eur J Pediatr (1993) 1.99
NKT cells are phenotypically and functionally diverse. Eur J Immunol (1999) 1.97
A mouse serine/threonine kinase homologous to C. elegans UNC51 functions in parallel fiber formation of cerebellar granule neurons. Neuron (1999) 1.95
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol (1999) 1.89
Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. Lab Invest (1978) 1.89
Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells. J Exp Med (1999) 1.88
Extrathymic development of V alpha 14-positive T cells. J Exp Med (1993) 1.88
Genetic studies of autoimmunity in New Zealand mice. III. Associations among anti-DNA antibodies, NTA, and renal disease in (NZB x NZW)F1 x NZW backcross mice. J Immunol (1981) 1.88
Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry (2003) 1.86
Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes (1987) 1.86
Chk2 activation dependence on Nbs1 after DNA damage. Mol Cell Biol (2001) 1.85
Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma. Nature (1980) 1.84
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol (2000) 1.82
A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. Am J Transplant (2009) 1.81
Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum (2001) 1.78
alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol (2000) 1.77
Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development (1997) 1.77
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer (2001) 1.77
Effect of type I interferon on experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm (1998) 1.76
Mouse ULK2, a novel member of the UNC-51-like protein kinases: unique features of functional domains. Oncogene (1999) 1.76
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation. Proc Natl Acad Sci U S A (1999) 1.76
ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med (2001) 1.74
Presence of interchain disulfide bonds between two gene products that compose the secreted form of an antigen-specific suppressor factor. J Exp Med (1981) 1.73
Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy (2009) 1.71
Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules. J Nucl Med (2001) 1.71
B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sci U S A (1988) 1.70
Nitrogen-dependent accumulation of cytokinins in root and the translocation to leaf: implication of cytokinin species that induces gene expression of maize response regulator. Plant Cell Physiol (2001) 1.70
A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol (1999) 1.69
Genes encoding pseudo-response regulators: insight into His-to-Asp phosphorelay and circadian rhythm in Arabidopsis thaliana. Plant Cell Physiol (2000) 1.69
Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene (1999) 1.68
Probable assignment of soluble isocitrate dehydrogenase (IDH1) to 2q33.3. Hum Genet (1985) 1.66
Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology (2001) 1.65
Compilation and characterization of Arabidopsis thaliana response regulators implicated in His-Asp phosphorelay signal transduction. Plant Cell Physiol (1999) 1.65
Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation. J Immunol (1971) 1.65
Dominant expression of a distinctive V14+ T-cell antigen receptor alpha chain in mice. Proc Natl Acad Sci U S A (1991) 1.63
Expression of novel DNA-binding protein with zinc finger structure in various tumor cells. J Biol Chem (1990) 1.61
Regulation of homocytotropic antibody formation in the rat. 8. An antigen-specific T cell factor that regulates anti-hapten homocytotropic antibody response. J Immunol (1973) 1.61
Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol (1997) 1.58
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol (2000) 1.57
Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. Proc Natl Acad Sci U S A (1995) 1.57
Newly identified genes involved in the signal transduction of Escherichia coli K-12. Gene (1994) 1.56
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res (1999) 1.55
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol (2001) 1.55
mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO J (1995) 1.54
Superconducting coherence peak in the electronic excitations of a single-layer Bi2Sr1.6La0.4CuO6+delta cuprate superconductor. Phys Rev Lett (2008) 1.53
NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol (2001) 1.52
Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol (1990) 1.52
A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors. Gastroenterology (1998) 1.52
Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem (2001) 1.51
The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol Cell Biol (2001) 1.51